Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Anxiety Disorders × Dronabinol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 3 Pain 3 Nausea 3 Parasomnias 1 Pancreatic Neoplasms 1 Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Anxiety Disorders 1

Interventions

Psychiatric Rehabilitation 8 Music Therapy 8 Therapeutics 6 Cognitive Behavioral Therapy 6 Acupuncture Therapy 5 Standard of Care 4 Mindfulness 4 Methods 4 Autogenic Training 4 Art Therapy 4 Therapeutic Touch 3 Psilocybin 3 Mindfulness-Based Stress Reduction 3 Imagery, Psychotherapy 3 Hypnosis 3 Early Intervention, Educational 3 Counseling 3 Control Groups 3 Acceptance and Commitment Therapy 3 Yoga 2 Touch 2 Surveys and Questionnaires 2 Psychosocial Intervention 2 Niacin 2 Mindfulness-Based Cognitive Therapy 2 Massage 2 Exercise Therapy 2 Exercise 2 Educational Status 2 Behavior Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡